AIS's Health Business Daily is a daily email newsletter with strategic business stories written by experienced AIS Health reporters, as well as other information of interest to health care business leaders — including news from the nation’s leading health insurers, developments from the federal and state governments that impact the health care industry, and exclusive datapoints from Subscribe now to get an issue delivered to your inbox every morning!
November 8, 2017
Headlines in the News
Axios, Nov. 7, 2017
Today's AIS Health Datapoint
2,362,678 ... people are enrolled in a Blues-branded Medicare Advantage plan offering as of October 2017. This represents 13.14% of the nationwide MA market.
AIS's Medicare and Medicaid Market Data: Enrollment, Premium Rates, Benefit Designs and Strategies of Medicare and Medicaid Plans

Quote of the Day
The therapy is “life changing for those individuals who receive a benefit from this.” They go “from darkness” and perhaps being “dependent on others” to gaining “independence, mobility and a significant increase in quality of life….The juice is worth the squeeze.”
— Stephen M. Rose, Ph.D., chief research officer at the Foundation Fighting Blindness, tells AIS Health about Spark Therapeutics Inc.’s Luxturna (voretigene neparvovec), which if approved by the FDA would be the first therapy where a corrective gene is given to a patient. The drug, which treats a condition that causes blindness, also may be the first therapy in the United States to top $1 million for a single patient.

The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Questions or suggestions about the content in AIS's HEALTH BUSINESS DAILY should be directed to Executive Editor Jill Brown at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2017 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. For more information, contact

With archives of AIS's Health Business Daily, features like the News Archives, AIS Blogs and more! (Free registration required)